HOME
/
TRANSACTIONS
/
DERMAPHARM AG
Well, we have just completed our third transaction in four years with IMAP. We have successfully attracted the first investment from an Indian group and most recently we have successfully partnered up with Dermapharm AG of Germany, a leading generic drug producer in the EU. As a result, we will gain access to new products, and we will have a much lower entry price of drugs and raw materials. With a new owner we ensure better financial restructuring and further growth in our share of the regional markets. Given the economic situation this is essential.
Not one of these deals were easy and even though we have become transaction experts and M&A scholars we always have relished and relied upon the thoughtful, energetic and professional help that Jurgis and his team bring to the deal.
Our company's four pillars are: quality, customer relationships, employees and socially responsible conduct. In many ways IMAP mirrors these with its own way of doing things. They are delivering a quality product with the client centre stage. They work as a real team, taking as much of the stress from the process and their approach has always been fair, honest and rigorous. Thank you!
